Development and characterization of biocompatible isotropic and anisotropic oil-in-water colloidal dispersions as a new delivery system for methyl dihydrojasmonate antitumor drug

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 867-876

  da Silva, Gisela Bevilacqua Rolfsen Ferreira ^a   Scarpa, Maria Virginia ^a   Rossanezi, Gustavo ^a   do Egito, Eryvaldo Socrates Tabosa ^b   de Oliveira, Anselmo Gomes ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Anticancer drug; Biocompatible microemulsions; Methyl dihydrojasmonate; Microemulsion characterization; Pseudo ternary phase diagram

Indexed keywords

ANTINEOPLASTIC AGENT; BIOMATERIAL; COLLOID; CYCLOPENTANE DERIVATIVE; EMULSION; METHYLDIHYDROJASMONATE; NANOMATERIAL; OIL; WATER;

CHEMISTRY; COLLOID; DRUG DELIVERY SYSTEM; EMULSION; FLOW KINETICS; HUMAN; MEDICINAL CHEMISTRY; NANOMEDICINE; SOLUBILITY; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; CHEMISTRY, PHARMACEUTICAL; COLLOIDS; CYCLOPENTANES; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; NANOMEDICINE; NANOSTRUCTURES; OILS; RHEOLOGY; SOLUBILITY; WATER;

EID: 84893781453     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S46055     Document Type: Article

References (31)

1. Formariz TP, Sarmento VHV, Silva-Junior AA, Scarpa MV, Santilli CV, Oliveira AG. Doxorubicin biocompatible O/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine. Colloids Surf B Biointerfaces. 2006;51:54-61.
2. Formariz TP, Urban MCC, Silva-Júnior AA, Gremião MD, Oliveira AG. Microemulsões e fases líquidas cristalinas como sistemas de liberação de fármacos. Braz J Pharm Sci. 2005;41:301-313.
3. Oliveira AG, Chiavacci LA, Scarpa MV, Egito EST. Microemulsions: physico-chemical approaches on the system for pharmaceutical applications. In: Li SJ, editor. Current Focus on Colloids and Surfaces. Kerala, India: Transworld Research Network; 2009:57-84.
4. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89-121.
5. Correa MA, Scarpa MV, Franzini MC, Oliveira AG. On the incorporation of the non-steroidal anti-inflammatory naproxen into cationic O/W microemulsions. Colloids Surf B Biointerfaces. 2005;43:108-114.
6. Pestana KC, Formariz TP, Franzini CM, et al. Oil-in-water lecithin based microemulsions as a potential delivery system for amphotericin. Colloids Surf B Biointerfaces. 2008;66:253-259.
7. Formariz TP, Chiavacci LA, Sarmento VHV, Santilli CV, Tabosa do Egito ES, Oliveira AG. Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion. Colloids Surf B Biointerfaces. 2007;60:28-35.
8. Formariz TP, Chiavacci LA, Sarmento VHV, et al. Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidilcholine and their relationhship with doxo rubicin release. Colloids Surf B Biointerfaces. 2008;63:287-295.
9. Franzini MC, Pestana KC, Molina EF, Scarpa MV, Egito EST, Oliveira AG. Structural properties induced by the composition of biocompatible phospholipid-based microemulsion and amphotericin B association. J Biomed Nanotech. 2012;8:350-359.
10. Assumpção JUCV, Campos ML, Nogueira Filho MAF, et al. Biocompatible microemulsion modifies the pharmacokinetic profile and cardiotoxicity of doxorubicin. J Pharm Sci. 2013;102:289-296.
11. Farmer EE, Ryan CA. Interplant communication: air-borne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves. Proc Natl Acad Sci U S A. 1990;87:7713-7716.
12. Yeruva L, Elegbede JA, Carper SW. Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells. Anticancer Drugs. 2008;19:766-776.
13. Conti M. Cyclopentenone: a special moiety for anticancer drug design. Anticancer Drugs. 2006;17:1017-1022.
14. Avanci NC, Luche DD, Goldman GH, Goldman MHS. Jasmonates are phytohormones with multiple functions, including plant defense and reproduction. Genet Mol Res. 2010;9:484-505.
15. Flescher E. Jasmonates in cancer therapy. Cancer Lett. 2007;245:1-10.
16. Fingrut O, Reischer D, Rotem R, et al. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. Br J Pharmacol. 2005;146:800-808.
17. Cohen E, Flescher E. Methyl jasmonate: a plant stress hormone as an anti-cancer drug. Phytochemistry. 2009;70:1600-1609.
18. Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res. 2005;65:1984-1993.
19. Kim JH, Lee JY, Oh SY, et al. Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells. Oncol Rep. 2004;12:1233-1238.
20. Reischer D, Heyfets A, Shimony S, Nordenberg J, Kashman Y, Flescher E. Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma. Br J Pharmacol. 2007;150:739-749.
21. Oliveira AG, Rossanezzi G, Formariz TP, Egito EST, Scarpa MV. Effect of cationic micelles on the decomposition of alpha-aminophenyl cephalosporins. Colloids Surf B Biointerfaces. 2010;79:372-376.
22. Oliveira AG, Scarpa MV, Chaimovich H. Effect of hexadecyltrimeth-ylammonium bromide-based microemulsions on the rate of decomposition of the beta-lactam antibiotic cephaclor. J Pharm Sci. 1997;86: 616-620.
23. Kumar R, Katare OP. Lecithin organogels as a potential phospholipidstructured system for topical drug delivery: a review. AAPS Pharm Sci Tech. 2005;6:298-310.
24. Trotta M, Pattarino F, Ignono T. Stability of frug carrier emulsions containing phosphatidylcholine mixtures. Eur J Pharm Biopharm. 2002;53:203-208.
25. Trotta M. Influence of phase transformation on indomethacin release from microemulsions. J Control Release. 1999;60:399-405.
26. Oliveira AG, Nothenberg MS, Cuccovia IM, Chaimovich H. Micellar catalysis of the intramolecular aminolysis of the β-lactam antibiotic cephaclor. J Phys Org Chem. 1991;4:19-24.
27. Schreier S, Malheiros SV, Paula E. Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochim Biophys Acta. 2000;1508:210-234.
28. Formariz TP, Wanczinski BJ, Júnior-Silva AA, Scar pa MV, Oliveira AG. Biotecnologia de sistemas coloidais aplicável na otimização do efeito terapêutico de fármacos usados no tratamento do câncer. Infarma. 2004;16:44-57.
29. Atkinson HV. Modeling the semisolid processing of metallic alloys. Prog Mater Sci. 2005;50:341-412.
30. Chen ZQ, Dai ZG. Colloid Chemistry. Beijing: Higher Education Press; 1984.
31. Gabboun NH, Najib NM, Ibrahim HG, Assaf S. Release of salicylic acid, diclofenac acid and diclofenac acid salts from isotropic and anisotropic nonionic surfactant systems across rat skin. Int J Pharm. 2001;212:73-80.